Logo
x

Search category

Subscribe Now

All Posts by Date

Insights+: The US FDA New Drug Approvals in June 2022

Insights+: The US FDA New Drug Approvals in June 2022

  • July 21, 2022
Takeda Reports P-III (ADVANCE-1) Trial Results of Hyqvia as Maintenance Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Takeda Reports P-III (ADVANCE-1) Trial Results of Hyqvia as Maintenance Treatment of Chronic Inflammatory Demyelinating Polyradicu...

  • July 21, 2022
ITM Entered into a Clinical Supply Agreement with Y-mAbs for n.c.a. Lutetium-177 to Treat Solid Tumors

ITM Entered into a Clinical Supply Agreement with Y-mAbs for n.c.a. Lutetium-177 to Treat Solid Tumors

  • July 21, 2022
Eiger's Zokinvy (ionafarnib) Receives EC's Marketing Authorization for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies

Eiger's Zokinvy (ionafarnib) Receives EC's Marketing Authorization for Hutchinson-Gilford Progeria Syndrome and Processing-Deficie...

  • July 21, 2022
LEO Pharma Reports 32-Week Results from a Post-hoc Analysis of Adbry (tralokinumab-ldrm) in P-III (ECZTRA 3) Trial for Atopic Dermatitis

LEO Pharma Reports 32-Week Results from a Post-hoc Analysis of Adbry (tralokinumab-ldrm) in P-III (ECZTRA 3) Trial for Atopic Derm...

  • July 21, 2022
Alvotech Reports the Initiation of Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia and Xgeva to Treat Bone Disease

Alvotech Reports the Initiation of Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia and Xgeva to Treat Bone Disea...

  • July 21, 2022
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.